CoChat

Impairment of GLP1 ‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia

Herzberg‐Schäfer, S., Heni, M., Stefan, N., Häring, H.‐U., Fritsche, A. · 2012 · Diabetes, Obesity and Metabolism
Cited by 57

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

One major risk factor of type 2 diabetes is the impairment of glucose‐induced insulin secretion which is mediated by the individual genetic background and environmental factors. In addition to impairment of glucose‐induced insulin secretion, impaired glucagon‐like peptide ( GLP )1‐induced insulin secretion has been identified to be present in subjects with diabetes and impaired glucose tolerance, but little is known about its fundamental mechanisms. The state of GLP1 resistance is probably an important mechanism explaining the reduced incretin effect observed in type 2 diabetes. In this review, we address methods that can be used for the measurement of insulin secretion in response to GLP1 in humans, and studies showing that specific diabetes risk genes are associated with resistance of the secretory function of the β‐cell in response to GLP1 administration. Furthermore, we discuss other factors that are associated with impaired GLP1 ‐induced insulin secretion, for example, insulin resistance. Finally, we provide evidence that hyperglycaemia per se , the genetic background and their interaction result in the development of GLP1 resistance of the β‐cell. We speculate that the response or the non‐response to therapy with GLP1 analogues and/or dipeptidyl peptidase‐4 ( DPP‐IV ) inhibitors is critically dependent on GLP1 resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2012.01648.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 57

Metadata

Authors
Herzberg‐Schäfer, S., Heni, M., Stefan, N., Häring, H. ‐., & Fritsche, A.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2012-08-28
Volume
14
Issue
s3
Pages
85-90
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2097598130
Cited by
57
References
10
FWCI
5.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impairment of GLP1 ‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia. https://app.cochat.ai/papers/10.1111/j.1463-1326.2012.01648.x
The paper
Herzberg‐Schäfer, S., Heni, M., Stefan, N., Häring, H. ‐., & Fritsche, A. (2012). Impairment of GLP1 ‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2012.01648.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.